Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Index by author

October 01, 1996; Volume 24,Issue 10
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Anderson, B D

    1. You have access
      Role of altered metabolism in dideoxynucleoside pharmacokinetics. Studies of 2'-beta-fluoro-2',3'-dideoxyinosine and 2'-beta-fluoro-2',3'-dideoxyadenosine in rats.
      D Singhal, M E Morgan and B D Anderson
      Drug Metabolism and Disposition October 1996, 24 (10) 1155-1161;
  2. Assmann, G

    1. You have access
      Characterization of glucuronidated phase II metabolites of the immunosuppressant cyclosporine in urine of transplant patients using time-of-flight secondary-ion mass spectrometry.
      K Meyer, M Fobker, U Christians, M Erren, K F Sewing, G Assmann and A Benninghoven
      Drug Metabolism and Disposition October 1996, 24 (10) 1151-1154;

B

  1. Balani, S K

    1. You have access
      Species differences in the pharmacokinetics and metabolism of indinavir, a potent human immunodeficiency virus protease inhibitor.
      J H Lin, M Chiba, S K Balani, I W Chen, G Y Kwei, K J Vastag and J A Nishime
      Drug Metabolism and Disposition October 1996, 24 (10) 1111-1120;
  2. Beattie, I

    1. You have access
      Excretion and metabolism of tipredane, a novel glucocorticoid, in the rat, mouse, monkey, and human.
      A E Cooper, A J Gray, J Collington, H Seddon, I Beattie and C J Logan
      Drug Metabolism and Disposition October 1996, 24 (10) 1071-1080;
  3. Benninghoven, A

    1. You have access
      Characterization of glucuronidated phase II metabolites of the immunosuppressant cyclosporine in urine of transplant patients using time-of-flight secondary-ion mass spectrometry.
      K Meyer, M Fobker, U Christians, M Erren, K F Sewing, G Assmann and A Benninghoven
      Drug Metabolism and Disposition October 1996, 24 (10) 1151-1154;
  4. Bible, R

    1. You have access
      Isolation and identification of metabolites of leukotriene A4 hydrolase inhibitor SC-57461 in rats.
      J H Yuan, J Birkmeier, D C Yang, J D Hribar, N Liu, R Bible, E Hajdu, M Rock and G Schoenhard
      Drug Metabolism and Disposition October 1996, 24 (10) 1124-1133;
  5. Birkmeier, J

    1. You have access
      Isolation and identification of metabolites of leukotriene A4 hydrolase inhibitor SC-57461 in rats.
      J H Yuan, J Birkmeier, D C Yang, J D Hribar, N Liu, R Bible, E Hajdu, M Rock and G Schoenhard
      Drug Metabolism and Disposition October 1996, 24 (10) 1124-1133;
  6. Brophy, P

    1. You have access
      Disposition of a novel recombinant antithrombotic agent, RG 12986, in cynomolgus monkeys.
      D S Wells, R Hensel, C Loullis, P Brophy, M E Mullin, E Murray and G Ricca
      Drug Metabolism and Disposition October 1996, 24 (10) 1102-1106;
  7. Brune, K

    1. You have access
      Transfer of different nonsteroidal antiinflammatory drugs via the lymphatic system in the rat.
      R Oelkers, M Ionac, K Erb, K Brune and G Geisslinger
      Drug Metabolism and Disposition October 1996, 24 (10) 1107-1110;

C

  1. Chen, I W

    1. You have access
      Species differences in the pharmacokinetics and metabolism of indinavir, a potent human immunodeficiency virus protease inhibitor.
      J H Lin, M Chiba, S K Balani, I W Chen, G Y Kwei, K J Vastag and J A Nishime
      Drug Metabolism and Disposition October 1996, 24 (10) 1111-1120;
  2. Chiba, M

    1. You have access
      Species differences in the pharmacokinetics and metabolism of indinavir, a potent human immunodeficiency virus protease inhibitor.
      J H Lin, M Chiba, S K Balani, I W Chen, G Y Kwei, K J Vastag and J A Nishime
      Drug Metabolism and Disposition October 1996, 24 (10) 1111-1120;
  3. Christians, U

    1. You have access
      Characterization of glucuronidated phase II metabolites of the immunosuppressant cyclosporine in urine of transplant patients using time-of-flight secondary-ion mass spectrometry.
      K Meyer, M Fobker, U Christians, M Erren, K F Sewing, G Assmann and A Benninghoven
      Drug Metabolism and Disposition October 1996, 24 (10) 1151-1154;
  4. Coleman, N L

    1. You have access
      Stereoselective disposition of the enantiomers of the benzoquinolinone LY191704, a human type I 5 alpha-reductase inhibitor. Differences between rats and dogs.
      N A Farid, K M Schreiner, N L Coleman, R B Van Lier and S A Wrighton
      Drug Metabolism and Disposition October 1996, 24 (10) 1162-1165;
  5. Collington, J

    1. You have access
      Excretion and metabolism of tipredane, a novel glucocorticoid, in the rat, mouse, monkey, and human.
      A E Cooper, A J Gray, J Collington, H Seddon, I Beattie and C J Logan
      Drug Metabolism and Disposition October 1996, 24 (10) 1071-1080;
  6. Cooper, A E

    1. You have access
      Excretion and metabolism of tipredane, a novel glucocorticoid, in the rat, mouse, monkey, and human.
      A E Cooper, A J Gray, J Collington, H Seddon, I Beattie and C J Logan
      Drug Metabolism and Disposition October 1996, 24 (10) 1071-1080;

D

  1. Danielson, T J

    1. You have access
      Systemic clearance and demethylation of caffeine in sheep and cattle.
      T J Danielson and L R Golsteyn
      Drug Metabolism and Disposition October 1996, 24 (10) 1058-1061;
  2. Drobitch, R K

    1. You have access
      Fluoroquinolone antibiotics inhibit cytochrome P450-mediated microsomal drug metabolism in rat and human.
      R A McLellan, R K Drobitch, M Monshouwer and K W Renton
      Drug Metabolism and Disposition October 1996, 24 (10) 1134-1138;

E

  1. Erb, K

    1. You have access
      Transfer of different nonsteroidal antiinflammatory drugs via the lymphatic system in the rat.
      R Oelkers, M Ionac, K Erb, K Brune and G Geisslinger
      Drug Metabolism and Disposition October 1996, 24 (10) 1107-1110;
  2. Erren, M

    1. You have access
      Characterization of glucuronidated phase II metabolites of the immunosuppressant cyclosporine in urine of transplant patients using time-of-flight secondary-ion mass spectrometry.
      K Meyer, M Fobker, U Christians, M Erren, K F Sewing, G Assmann and A Benninghoven
      Drug Metabolism and Disposition October 1996, 24 (10) 1151-1154;

F

  1. Farid, N A

    1. You have access
      Stereoselective disposition of the enantiomers of the benzoquinolinone LY191704, a human type I 5 alpha-reductase inhibitor. Differences between rats and dogs.
      N A Farid, K M Schreiner, N L Coleman, R B Van Lier and S A Wrighton
      Drug Metabolism and Disposition October 1996, 24 (10) 1162-1165;
  2. Fobker, M

    1. You have access
      Characterization of glucuronidated phase II metabolites of the immunosuppressant cyclosporine in urine of transplant patients using time-of-flight secondary-ion mass spectrometry.
      K Meyer, M Fobker, U Christians, M Erren, K F Sewing, G Assmann and A Benninghoven
      Drug Metabolism and Disposition October 1996, 24 (10) 1151-1154;
  3. Fournel-Gigleux, S

    1. You have access
      Stereoselective irreversible binding of ketoprofen glucuronides to albumin. Characterization of the site and the mechanism.
      N Presle, F Lapicque, S Fournel-Gigleux, J Magdalou and P Netter
      Drug Metabolism and Disposition October 1996, 24 (10) 1050-1057;
  4. Fromm, M F

    1. You have access
      The nifedipine-rifampin interaction. Evidence for induction of gut wall metabolism.
      N Holtbecker, M F Fromm, H K Kroemer, E E Ohnhaus and H Heidemann
      Drug Metabolism and Disposition October 1996, 24 (10) 1121-1123;

G

  1. Geisslinger, G

    1. You have access
      Transfer of different nonsteroidal antiinflammatory drugs via the lymphatic system in the rat.
      R Oelkers, M Ionac, K Erb, K Brune and G Geisslinger
      Drug Metabolism and Disposition October 1996, 24 (10) 1107-1110;
  2. Ghanayem, B I

    1. You have access
      Human CYP2C19 is a major omeprazole 5-hydroxylase, as demonstrated with recombinant cytochrome P450 enzymes.
      W G Karam, J A Goldstein, J M Lasker and B I Ghanayem
      Drug Metabolism and Disposition October 1996, 24 (10) 1081-1087;
  3. Goldstein, J A

    1. You have access
      Human CYP2C19 is a major omeprazole 5-hydroxylase, as demonstrated with recombinant cytochrome P450 enzymes.
      W G Karam, J A Goldstein, J M Lasker and B I Ghanayem
      Drug Metabolism and Disposition October 1996, 24 (10) 1081-1087;
  4. Golsteyn, L R

    1. You have access
      Systemic clearance and demethylation of caffeine in sheep and cattle.
      T J Danielson and L R Golsteyn
      Drug Metabolism and Disposition October 1996, 24 (10) 1058-1061;
  5. Gray, A J

    1. You have access
      Excretion and metabolism of tipredane, a novel glucocorticoid, in the rat, mouse, monkey, and human.
      A E Cooper, A J Gray, J Collington, H Seddon, I Beattie and C J Logan
      Drug Metabolism and Disposition October 1996, 24 (10) 1071-1080;

H

  1. Hajdu, E

    1. You have access
      Isolation and identification of metabolites of leukotriene A4 hydrolase inhibitor SC-57461 in rats.
      J H Yuan, J Birkmeier, D C Yang, J D Hribar, N Liu, R Bible, E Hajdu, M Rock and G Schoenhard
      Drug Metabolism and Disposition October 1996, 24 (10) 1124-1133;
  2. Heidemann, H

    1. You have access
      The nifedipine-rifampin interaction. Evidence for induction of gut wall metabolism.
      N Holtbecker, M F Fromm, H K Kroemer, E E Ohnhaus and H Heidemann
      Drug Metabolism and Disposition October 1996, 24 (10) 1121-1123;
  3. Hensel, R

    1. You have access
      Disposition of a novel recombinant antithrombotic agent, RG 12986, in cynomolgus monkeys.
      D S Wells, R Hensel, C Loullis, P Brophy, M E Mullin, E Murray and G Ricca
      Drug Metabolism and Disposition October 1996, 24 (10) 1102-1106;
  4. Holtbecker, N

    1. You have access
      The nifedipine-rifampin interaction. Evidence for induction of gut wall metabolism.
      N Holtbecker, M F Fromm, H K Kroemer, E E Ohnhaus and H Heidemann
      Drug Metabolism and Disposition October 1996, 24 (10) 1121-1123;
  5. Hrib, N

    1. You have access
      Metabolism of an atypical antipsychotic agent, 3-[4-[4-(6-fluorobenzo[b]thien-3-yl)-1-piperazinyl]butyl]-2, 5,5-trimethyl-4-thiazolidinone (HP236).
      A E Mutlib, J Jurcak and N Hrib
      Drug Metabolism and Disposition October 1996, 24 (10) 1139-1150;
  6. Hribar, J D

    1. You have access
      Isolation and identification of metabolites of leukotriene A4 hydrolase inhibitor SC-57461 in rats.
      J H Yuan, J Birkmeier, D C Yang, J D Hribar, N Liu, R Bible, E Hajdu, M Rock and G Schoenhard
      Drug Metabolism and Disposition October 1996, 24 (10) 1124-1133;

I

  1. Ionac, M

    1. You have access
      Transfer of different nonsteroidal antiinflammatory drugs via the lymphatic system in the rat.
      R Oelkers, M Ionac, K Erb, K Brune and G Geisslinger
      Drug Metabolism and Disposition October 1996, 24 (10) 1107-1110;

J

  1. Jurcak, J

    1. You have access
      Metabolism of an atypical antipsychotic agent, 3-[4-[4-(6-fluorobenzo[b]thien-3-yl)-1-piperazinyl]butyl]-2, 5,5-trimethyl-4-thiazolidinone (HP236).
      A E Mutlib, J Jurcak and N Hrib
      Drug Metabolism and Disposition October 1996, 24 (10) 1139-1150;

K

  1. Karam, W G

    1. You have access
      Human CYP2C19 is a major omeprazole 5-hydroxylase, as demonstrated with recombinant cytochrome P450 enzymes.
      W G Karam, J A Goldstein, J M Lasker and B I Ghanayem
      Drug Metabolism and Disposition October 1996, 24 (10) 1081-1087;
  2. Kocarek, T A

    1. You have access
      Regulation of rat hepatic sulfotransferase gene expression by glucocorticoid hormones.
      M Runge-Morris, K Rose and T A Kocarek
      Drug Metabolism and Disposition October 1996, 24 (10) 1095-1101;
  3. Kroemer, H K

    1. You have access
      The nifedipine-rifampin interaction. Evidence for induction of gut wall metabolism.
      N Holtbecker, M F Fromm, H K Kroemer, E E Ohnhaus and H Heidemann
      Drug Metabolism and Disposition October 1996, 24 (10) 1121-1123;
  4. Kwei, G Y

    1. You have access
      Species differences in the pharmacokinetics and metabolism of indinavir, a potent human immunodeficiency virus protease inhibitor.
      J H Lin, M Chiba, S K Balani, I W Chen, G Y Kwei, K J Vastag and J A Nishime
      Drug Metabolism and Disposition October 1996, 24 (10) 1111-1120;

L

  1. Lapicque, F

    1. You have access
      Stereoselective irreversible binding of ketoprofen glucuronides to albumin. Characterization of the site and the mechanism.
      N Presle, F Lapicque, S Fournel-Gigleux, J Magdalou and P Netter
      Drug Metabolism and Disposition October 1996, 24 (10) 1050-1057;
  2. Lasker, J M

    1. You have access
      Human CYP2C19 is a major omeprazole 5-hydroxylase, as demonstrated with recombinant cytochrome P450 enzymes.
      W G Karam, J A Goldstein, J M Lasker and B I Ghanayem
      Drug Metabolism and Disposition October 1996, 24 (10) 1081-1087;
  3. Lin, J H

    1. You have access
      Species differences in the pharmacokinetics and metabolism of indinavir, a potent human immunodeficiency virus protease inhibitor.
      J H Lin, M Chiba, S K Balani, I W Chen, G Y Kwei, K J Vastag and J A Nishime
      Drug Metabolism and Disposition October 1996, 24 (10) 1111-1120;
  4. Liu, N

    1. You have access
      Isolation and identification of metabolites of leukotriene A4 hydrolase inhibitor SC-57461 in rats.
      J H Yuan, J Birkmeier, D C Yang, J D Hribar, N Liu, R Bible, E Hajdu, M Rock and G Schoenhard
      Drug Metabolism and Disposition October 1996, 24 (10) 1124-1133;
  5. Logan, C J

    1. You have access
      Excretion and metabolism of tipredane, a novel glucocorticoid, in the rat, mouse, monkey, and human.
      A E Cooper, A J Gray, J Collington, H Seddon, I Beattie and C J Logan
      Drug Metabolism and Disposition October 1996, 24 (10) 1071-1080;
  6. Loullis, C

    1. You have access
      Disposition of a novel recombinant antithrombotic agent, RG 12986, in cynomolgus monkeys.
      D S Wells, R Hensel, C Loullis, P Brophy, M E Mullin, E Murray and G Ricca
      Drug Metabolism and Disposition October 1996, 24 (10) 1102-1106;

M

  1. Magdalou, J

    1. You have access
      Stereoselective irreversible binding of ketoprofen glucuronides to albumin. Characterization of the site and the mechanism.
      N Presle, F Lapicque, S Fournel-Gigleux, J Magdalou and P Netter
      Drug Metabolism and Disposition October 1996, 24 (10) 1050-1057;
  2. McLellan, R A

    1. You have access
      Fluoroquinolone antibiotics inhibit cytochrome P450-mediated microsomal drug metabolism in rat and human.
      R A McLellan, R K Drobitch, M Monshouwer and K W Renton
      Drug Metabolism and Disposition October 1996, 24 (10) 1134-1138;
  3. Mehvar, R

    1. You have access
      Reversal of stereoselectivity in the hepatic availability of verapamil in isolated perfused rat livers. Role of protein binding.
      R Mehvar and J Reynolds
      Drug Metabolism and Disposition October 1996, 24 (10) 1088-1094;
  4. Meyer, K

    1. You have access
      Characterization of glucuronidated phase II metabolites of the immunosuppressant cyclosporine in urine of transplant patients using time-of-flight secondary-ion mass spectrometry.
      K Meyer, M Fobker, U Christians, M Erren, K F Sewing, G Assmann and A Benninghoven
      Drug Metabolism and Disposition October 1996, 24 (10) 1151-1154;
  5. Monshouwer, M

    1. You have access
      Fluoroquinolone antibiotics inhibit cytochrome P450-mediated microsomal drug metabolism in rat and human.
      R A McLellan, R K Drobitch, M Monshouwer and K W Renton
      Drug Metabolism and Disposition October 1996, 24 (10) 1134-1138;
  6. Morgan, M E

    1. You have access
      Role of altered metabolism in dideoxynucleoside pharmacokinetics. Studies of 2'-beta-fluoro-2',3'-dideoxyinosine and 2'-beta-fluoro-2',3'-dideoxyadenosine in rats.
      D Singhal, M E Morgan and B D Anderson
      Drug Metabolism and Disposition October 1996, 24 (10) 1155-1161;
  7. Mullin, M E

    1. You have access
      Disposition of a novel recombinant antithrombotic agent, RG 12986, in cynomolgus monkeys.
      D S Wells, R Hensel, C Loullis, P Brophy, M E Mullin, E Murray and G Ricca
      Drug Metabolism and Disposition October 1996, 24 (10) 1102-1106;
  8. Murray, E

    1. You have access
      Disposition of a novel recombinant antithrombotic agent, RG 12986, in cynomolgus monkeys.
      D S Wells, R Hensel, C Loullis, P Brophy, M E Mullin, E Murray and G Ricca
      Drug Metabolism and Disposition October 1996, 24 (10) 1102-1106;
  9. Mutlib, A E

    1. You have access
      Metabolism of an atypical antipsychotic agent, 3-[4-[4-(6-fluorobenzo[b]thien-3-yl)-1-piperazinyl]butyl]-2, 5,5-trimethyl-4-thiazolidinone (HP236).
      A E Mutlib, J Jurcak and N Hrib
      Drug Metabolism and Disposition October 1996, 24 (10) 1139-1150;

N

  1. Netter, P

    1. You have access
      Stereoselective irreversible binding of ketoprofen glucuronides to albumin. Characterization of the site and the mechanism.
      N Presle, F Lapicque, S Fournel-Gigleux, J Magdalou and P Netter
      Drug Metabolism and Disposition October 1996, 24 (10) 1050-1057;
  2. Nishime, J A

    1. You have access
      Species differences in the pharmacokinetics and metabolism of indinavir, a potent human immunodeficiency virus protease inhibitor.
      J H Lin, M Chiba, S K Balani, I W Chen, G Y Kwei, K J Vastag and J A Nishime
      Drug Metabolism and Disposition October 1996, 24 (10) 1111-1120;

O

  1. Obach, R S

    1. You have access
      The importance of nonspecific binding in in vitro matrices, its impact on enzyme kinetic studies of drug metabolism reactions, and implications for in vitro-in vivo correlations.
      R S Obach
      Drug Metabolism and Disposition October 1996, 24 (10) 1047-1049;
  2. Oelkers, R

    1. You have access
      Transfer of different nonsteroidal antiinflammatory drugs via the lymphatic system in the rat.
      R Oelkers, M Ionac, K Erb, K Brune and G Geisslinger
      Drug Metabolism and Disposition October 1996, 24 (10) 1107-1110;
  3. Ohnhaus, E E

    1. You have access
      The nifedipine-rifampin interaction. Evidence for induction of gut wall metabolism.
      N Holtbecker, M F Fromm, H K Kroemer, E E Ohnhaus and H Heidemann
      Drug Metabolism and Disposition October 1996, 24 (10) 1121-1123;

P

  1. Pollack, G M

    1. You have access
      Comparative toxicokinetics of methanol in pregnant and nonpregnant rodents.
      K W Ward and G M Pollack
      Drug Metabolism and Disposition October 1996, 24 (10) 1062-1070;
  2. Presle, N

    1. You have access
      Stereoselective irreversible binding of ketoprofen glucuronides to albumin. Characterization of the site and the mechanism.
      N Presle, F Lapicque, S Fournel-Gigleux, J Magdalou and P Netter
      Drug Metabolism and Disposition October 1996, 24 (10) 1050-1057;

R

  1. Renton, K W

    1. You have access
      Fluoroquinolone antibiotics inhibit cytochrome P450-mediated microsomal drug metabolism in rat and human.
      R A McLellan, R K Drobitch, M Monshouwer and K W Renton
      Drug Metabolism and Disposition October 1996, 24 (10) 1134-1138;
  2. Reynolds, J

    1. You have access
      Reversal of stereoselectivity in the hepatic availability of verapamil in isolated perfused rat livers. Role of protein binding.
      R Mehvar and J Reynolds
      Drug Metabolism and Disposition October 1996, 24 (10) 1088-1094;
  3. Ricca, G

    1. You have access
      Disposition of a novel recombinant antithrombotic agent, RG 12986, in cynomolgus monkeys.
      D S Wells, R Hensel, C Loullis, P Brophy, M E Mullin, E Murray and G Ricca
      Drug Metabolism and Disposition October 1996, 24 (10) 1102-1106;
  4. Rock, M

    1. You have access
      Isolation and identification of metabolites of leukotriene A4 hydrolase inhibitor SC-57461 in rats.
      J H Yuan, J Birkmeier, D C Yang, J D Hribar, N Liu, R Bible, E Hajdu, M Rock and G Schoenhard
      Drug Metabolism and Disposition October 1996, 24 (10) 1124-1133;
  5. Rose, K

    1. You have access
      Regulation of rat hepatic sulfotransferase gene expression by glucocorticoid hormones.
      M Runge-Morris, K Rose and T A Kocarek
      Drug Metabolism and Disposition October 1996, 24 (10) 1095-1101;
  6. Runge-Morris, M

    1. You have access
      Regulation of rat hepatic sulfotransferase gene expression by glucocorticoid hormones.
      M Runge-Morris, K Rose and T A Kocarek
      Drug Metabolism and Disposition October 1996, 24 (10) 1095-1101;

S

  1. Schoenhard, G

    1. You have access
      Isolation and identification of metabolites of leukotriene A4 hydrolase inhibitor SC-57461 in rats.
      J H Yuan, J Birkmeier, D C Yang, J D Hribar, N Liu, R Bible, E Hajdu, M Rock and G Schoenhard
      Drug Metabolism and Disposition October 1996, 24 (10) 1124-1133;
  2. Schreiner, K M

    1. You have access
      Stereoselective disposition of the enantiomers of the benzoquinolinone LY191704, a human type I 5 alpha-reductase inhibitor. Differences between rats and dogs.
      N A Farid, K M Schreiner, N L Coleman, R B Van Lier and S A Wrighton
      Drug Metabolism and Disposition October 1996, 24 (10) 1162-1165;
  3. Seddon, H

    1. You have access
      Excretion and metabolism of tipredane, a novel glucocorticoid, in the rat, mouse, monkey, and human.
      A E Cooper, A J Gray, J Collington, H Seddon, I Beattie and C J Logan
      Drug Metabolism and Disposition October 1996, 24 (10) 1071-1080;
  4. Sewing, K F

    1. You have access
      Characterization of glucuronidated phase II metabolites of the immunosuppressant cyclosporine in urine of transplant patients using time-of-flight secondary-ion mass spectrometry.
      K Meyer, M Fobker, U Christians, M Erren, K F Sewing, G Assmann and A Benninghoven
      Drug Metabolism and Disposition October 1996, 24 (10) 1151-1154;
  5. Singhal, D

    1. You have access
      Role of altered metabolism in dideoxynucleoside pharmacokinetics. Studies of 2'-beta-fluoro-2',3'-dideoxyinosine and 2'-beta-fluoro-2',3'-dideoxyadenosine in rats.
      D Singhal, M E Morgan and B D Anderson
      Drug Metabolism and Disposition October 1996, 24 (10) 1155-1161;

V

  1. Van Lier, R B

    1. You have access
      Stereoselective disposition of the enantiomers of the benzoquinolinone LY191704, a human type I 5 alpha-reductase inhibitor. Differences between rats and dogs.
      N A Farid, K M Schreiner, N L Coleman, R B Van Lier and S A Wrighton
      Drug Metabolism and Disposition October 1996, 24 (10) 1162-1165;
  2. Vastag, K J

    1. You have access
      Species differences in the pharmacokinetics and metabolism of indinavir, a potent human immunodeficiency virus protease inhibitor.
      J H Lin, M Chiba, S K Balani, I W Chen, G Y Kwei, K J Vastag and J A Nishime
      Drug Metabolism and Disposition October 1996, 24 (10) 1111-1120;

W

  1. Ward, K W

    1. You have access
      Comparative toxicokinetics of methanol in pregnant and nonpregnant rodents.
      K W Ward and G M Pollack
      Drug Metabolism and Disposition October 1996, 24 (10) 1062-1070;
  2. Wells, D S

    1. You have access
      Disposition of a novel recombinant antithrombotic agent, RG 12986, in cynomolgus monkeys.
      D S Wells, R Hensel, C Loullis, P Brophy, M E Mullin, E Murray and G Ricca
      Drug Metabolism and Disposition October 1996, 24 (10) 1102-1106;
  3. Wrighton, S A

    1. You have access
      Stereoselective disposition of the enantiomers of the benzoquinolinone LY191704, a human type I 5 alpha-reductase inhibitor. Differences between rats and dogs.
      N A Farid, K M Schreiner, N L Coleman, R B Van Lier and S A Wrighton
      Drug Metabolism and Disposition October 1996, 24 (10) 1162-1165;

Y

  1. Yang, D C

    1. You have access
      Isolation and identification of metabolites of leukotriene A4 hydrolase inhibitor SC-57461 in rats.
      J H Yuan, J Birkmeier, D C Yang, J D Hribar, N Liu, R Bible, E Hajdu, M Rock and G Schoenhard
      Drug Metabolism and Disposition October 1996, 24 (10) 1124-1133;
  2. Yuan, J H

    1. You have access
      Isolation and identification of metabolites of leukotriene A4 hydrolase inhibitor SC-57461 in rats.
      J H Yuan, J Birkmeier, D C Yang, J D Hribar, N Liu, R Bible, E Hajdu, M Rock and G Schoenhard
      Drug Metabolism and Disposition October 1996, 24 (10) 1124-1133;
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition
Vol. 24, Issue 10
1 Oct 1996
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.
  • Prediction of Human Clearance of Twenty-Nine Drugs from Hepatic Microsomal Intrinsic Clearance Data: An Examination of In Vitro Half-Life Approach and Nonspecific Binding to Microsomes
  • DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
  • In Vitro-In Vivo Scaling of CYP Kinetic Data Not Consistent with the Classical Michaelis-Menten Model
  • THE HUMAN INTESTINAL CYTOCHROME P450 “PIE”
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics